NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

臨床檢驗的全球市場:各類型,各終端用戶的預測(到2025年)- COVID-19累積的影響

Clinical Laboratory Tests Market Research Report by Type, by End-user, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 998393
出版日期 內容資訊 英文 191 Pages
商品交期: 最快1-2個工作天內
價格
臨床檢驗的全球市場:各類型,各終端用戶的預測(到2025年)- COVID-19累積的影響 Clinical Laboratory Tests Market Research Report by Type, by End-user, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 191 Pages
簡介

全球臨床檢驗的市場規模,預計從2020年的287億3,769萬美元,擴大至2025年末為411億7,673萬美元。

COVID-19是影響幾乎全部產業的無與倫比的世界公共衛生緊急事件,在預測期間內預計帶給產業的成長長期性的影響。

本報告提供全球臨床檢驗市場的相關調查,市場機會和課題,成長及阻礙因素,COVID-19累積的影響,各類型、終端用戶、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 序文

  • 調查目的
  • 市場區隔和涵蓋範圍
  • 調查期間
  • 貨幣和價格
  • 語言
  • 規定事項
  • 利害關係者

第2章 調查方法

  • 調查流程
    • 定義:調查目的
    • 決策:調查計劃
    • 準備:調查設備
    • 收集:資料來源
    • 分析:資料的解釋
    • 制定:資料檢驗
    • 公開:調查報告
    • 重複:報告的更新
  • 調查的實行
    • 開始:調查流程
    • 計劃:調查計劃的作成
    • 實行:調查的實施
    • 檢驗:發現與分析
    • 出版物:調查報告
  • 調查成果

第3章 摘要整理

  • 市場展望
  • 各類型市場展望
  • 各終端用戶市場展望
  • 各地區市場的展望
  • 其他競爭公司預測

第4章 市場概要

  • COVID-19累積的影響

第5章 市場洞察

  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
    • 課題
  • 波特的五力分析

第6章 各類型市場

  • 基本的代謝面板檢驗
  • BUN血肌酐檢驗
  • 血液常規檢查
  • 全面的代謝面板檢驗
  • 電解質檢驗
  • HbA1c檢驗
  • HGB/HCT檢驗
  • 血脂檢查
  • 肝面板檢驗
    • 自體免疫疾病
    • 膽管閉塞
    • 骨疾病
    • 肝炎
    • 肝癌
    • 肝硬化
  • 腎面板檢驗

第7章 各終端用戶市場

  • 中央檢驗室
  • 主要診所

第8章 南北美洲市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太地區市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第10章 歐洲,中東、非洲市場

  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第11章 競爭情形

  • FPNV定位矩陣
    • 象限
    • 事業策略
    • 產品的滿意度
  • 市場排行榜分析
  • 市場佔有率分析
  • 其他競爭公司的SWOT分析
  • 競爭模式
    • 合併和收購
    • 協定,合作,及夥伴關係
    • 新產品的銷售與強化
    • 投資與資金籌措
    • 評估,認識,擴大

第12章 企業簡介

  • Abbott Laboratories
  • Associated Regional and University Pathologists, Inc.
  • Bioscientia Institut fur Medizinische Diagnostik GmbH
  • Biosino Bio-technology and Science Inc.
  • Charles River Laboratories, Inc
  • Cinven
  • Clinical Reference Laboratory, Inc.
  • DaVita Inc
  • Eurofins Scientific
  • Fresenius Medical Care Holdings, Inc.
  • Fullerton Healthcare Corporation Limited
  • Healthscope
  • KingMed Diagnostics
  • Laboratory Corporation of America Holdings (LabCorp)
  • LifeLabs
  • Mayo Foundation for Medical Education and Research
  • Merck KgaA
  • Neogenomics Laboratories, Inc
  • Novartis International AG
  • OPKO Health, Inc.
  • PerkinElmer, Inc.
  • Qiagen .N.V.
  • Quest Diagnostics, Inc.
  • Siemens Healthineers AG
  • Sonic Healthcare Limited
  • Thermo Fisher Scientific Inc.

第13章 附錄

  • 討論指南
  • 許可證和價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-A339DAEFAC85

The Global Clinical Laboratory Tests Market size was estimated at USD 28.73 Billion in 2020 and expected to reach USD 31.02 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 8.29% to reach USD 46.36 Billion by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Clinical Laboratory Tests to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type , the Clinical Laboratory Tests Market was studied across Basic metabolic panel tests, BUN creatinine tests, Complete Blood Count, Comprehensive metabolic panel tests, Electrolytes testing, HbA1c tests, HGB/HCT tests, Lipid panel tests, Liver panel tests, and Renal panel tests. The Liver panel tests is further studied across Autoimmune disorders, Bile duct obstruction, Bone disease, Hepatitis, Liver Cancer, and Liver Cirrhosis.

Based on End-user, the Clinical Laboratory Tests Market was studied across Central Laboratories and Primary Clinics.

Based on Geography, the Clinical Laboratory Tests Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Clinical Laboratory Tests Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Clinical Laboratory Tests Market, including Abbott Laboratories, Associated Regional and University Pathologists, Inc., Bioscientia Institut fur Medizinische Diagnostik GmbH, Biosino Bio-technology and Science Inc., Charles River Laboratories, Inc, Cinven, Clinical Reference Laboratory, Inc., DaVita Inc, Eurofins Scientific, Fresenius Medical Care Holdings, Inc., Fullerton Healthcare Corporation Limited, Healthscope, KingMed Diagnostics, Laboratory Corporation of America Holdings (LabCorp), LifeLabs, Mayo Foundation for Medical Education and Research, Merck KgaA, Neogenomics Laboratories, Inc, Novartis International AG, OPKO Health, Inc., PerkinElmer, Inc., Qiagen .N.V., Quest Diagnostics, Inc., Siemens Healthineers AG, Sonic Healthcare Limited, and Thermo Fisher Scientific Inc..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Clinical Laboratory Tests Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Clinical Laboratory Tests Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Clinical Laboratory Tests Market?
  • 4. What is the competitive strategic window for opportunities in the Global Clinical Laboratory Tests Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Clinical Laboratory Tests Market?
  • 6. What is the market share of the leading vendors in the Global Clinical Laboratory Tests Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Clinical Laboratory Tests Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Type Outlook
  • 3.4. End-user Outlook
  • 3.5. Geography Outlook
  • 3.6. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of chronic diseases
      • 5.1.1.2. Rising demand for early disease detection
      • 5.1.1.3. Advancements in clinical diagnosis
      • 5.1.1.4. Supportive government initiatives for improved clinical diagnostic procedure
    • 5.1.2. Restraints
      • 5.1.2.1. With innovation increasing point of care or self-care tests
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing number of laboratories and demand due to COVID-19
      • 5.1.3.2. Increasing digitalization and automation in clinical testing
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of skills and training affect the test result reliability
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Clinical Laboratory Tests Market, by Type

  • 6.1. Introduction
  • 6.2. Basic metabolic panel tests
  • 6.3. BUN creatinine tests
  • 6.4. Complete Blood Count
  • 6.5. Comprehensive metabolic panel tests
  • 6.6. Electrolytes testing
  • 6.7. HbA1c tests
  • 6.8. HGB/HCT tests
  • 6.9. Lipid panel tests
  • 6.10. Liver panel tests
    • 6.10.1. Autoimmune disorders
    • 6.10.2. Bile duct obstruction
    • 6.10.3. Bone disease
    • 6.10.4. Hepatitis
    • 6.10.5. Liver Cancer
    • 6.10.6. Liver Cirrhosis
  • 6.11. Renal panel tests

7. Clinical Laboratory Tests Market, by End-user

  • 7.1. Introduction
  • 7.2. Central Laboratories
  • 7.3. Primary Clinics

8. Americas Clinical Laboratory Tests Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States
    • 8.6.1. California
    • 8.6.2. Florida
    • 8.6.3. Illinois
    • 8.6.4. New York
    • 8.6.5. Ohio
    • 8.6.6. Pennsylvania
    • 8.6.7. Texas

9. Asia-Pacific Clinical Laboratory Tests Market

  • 9.1. Introduction
  • 9.2. China
  • 9.3. India
  • 9.4. Indonesia
  • 9.5. Japan
  • 9.6. Malaysia
  • 9.7. Philippines
  • 9.8. South Korea
  • 9.9. Thailand

10. Europe, Middle East & Africa Clinical Laboratory Tests Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis, By Quadrant
  • 11.4. Market Share Analysis, By Company
  • 11.5. Competitive Scenario
    • 11.5.1. Merger & Acquisition
    • 11.5.2. Agreement, Collaboration, & Partnership
    • 11.5.3. New Product Launch & Enhancement
    • 11.5.4. Investment & Funding
    • 11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Abbott Laboratories
  • 12.2. Associated Regional and University Pathologists, Inc.
  • 12.3. Bioscientia Institut fur Medizinische Diagnostik GmbH
  • 12.4. Biosino Bio-technology and Science Inc.
  • 12.5. Charles River Laboratories, Inc
  • 12.6. Cinven
  • 12.7. Clinical Reference Laboratory, Inc.
  • 12.8. DaVita Inc
  • 12.9. Eurofins Scientific
  • 12.10. Fresenius Medical Care Holdings, Inc.
  • 12.11. Fullerton Healthcare Corporation Limited
  • 12.12. Healthscope
  • 12.13. KingMed Diagnostics
  • 12.14. Laboratory Corporation of America Holdings (LabCorp)
  • 12.15. LifeLabs
  • 12.16. Mayo Foundation for Medical Education and Research
  • 12.17. Merck KgaA
  • 12.18. Neogenomics Laboratories, Inc
  • 12.19. Novartis International AG
  • 12.20. OPKO Health, Inc.
  • 12.21. PerkinElmer, Inc.
  • 12.22. Qiagen .N.V.
  • 12.23. Quest Diagnostics, Inc.
  • 12.24. Siemens Healthineers AG
  • 12.25. Sonic Healthcare Limited
  • 12.26. Thermo Fisher Scientific Inc.

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing
  • 13.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, 2020 VS 2026 (USD BILLION)
  • FIGURE 2. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE , 2020 (USD BILLION)
  • FIGURE 3. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2020 (USD BILLION)
  • FIGURE 4. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2020 (USD BILLION)
  • FIGURE 5. GLOBAL CLINICAL LABORATORY TESTS MARKET: MARKET DYNAMICS
  • FIGURE 6. GLOBAL CLINICAL LABORATORY TESTS MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 7. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE , 2020 VS 2026 (%)
  • FIGURE 8. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE , 2020 VS 2026 (USD BILLION)
  • FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE , 2026
  • FIGURE 10. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL TESTS, 2018-2026 (USD BILLION)
  • FIGURE 11. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL TESTS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 12. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY BUN CREATININE TESTS, 2018-2026 (USD BILLION)
  • FIGURE 13. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY BUN CREATININE TESTS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 14. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPLETE BLOOD COUNT, 2018-2026 (USD BILLION)
  • FIGURE 15. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPLETE BLOOD COUNT, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 16. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL TESTS, 2018-2026 (USD BILLION)
  • FIGURE 17. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL TESTS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 18. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY ELECTROLYTES TESTING, 2018-2026 (USD BILLION)
  • FIGURE 19. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY ELECTROLYTES TESTING, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 20. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY HBA1C TESTS, 2018-2026 (USD BILLION)
  • FIGURE 21. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY HBA1C TESTS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 22. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY HGB/HCT TESTS, 2018-2026 (USD BILLION)
  • FIGURE 23. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY HGB/HCT TESTS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 24. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY LIPID PANEL TESTS, 2018-2026 (USD BILLION)
  • FIGURE 25. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY LIPID PANEL TESTS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 26. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY LIVER PANEL TESTS, 2018-2026 (USD BILLION)
  • FIGURE 27. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY LIVER PANEL TESTS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 28. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2026 (USD BILLION)
  • FIGURE 29. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 30. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY BILE DUCT OBSTRUCTION, 2018-2026 (USD BILLION)
  • FIGURE 31. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY BILE DUCT OBSTRUCTION, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 32. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY BONE DISEASE, 2018-2026 (USD BILLION)
  • FIGURE 33. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY BONE DISEASE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 34. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY HEPATITIS, 2018-2026 (USD BILLION)
  • FIGURE 35. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY HEPATITIS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 36. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY LIVER CANCER, 2018-2026 (USD BILLION)
  • FIGURE 37. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY LIVER CANCER, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 38. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY LIVER CIRRHOSIS, 2018-2026 (USD BILLION)
  • FIGURE 39. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY LIVER CIRRHOSIS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 40. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY RENAL PANEL TESTS, 2018-2026 (USD BILLION)
  • FIGURE 41. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY RENAL PANEL TESTS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 42. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2020 VS 2026 (%)
  • FIGURE 43. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2020 VS 2026 (USD BILLION)
  • FIGURE 44. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2026
  • FIGURE 45. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY CENTRAL LABORATORIES, 2018-2026 (USD BILLION)
  • FIGURE 46. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY CENTRAL LABORATORIES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 47. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY PRIMARY CLINICS, 2018-2026 (USD BILLION)
  • FIGURE 48. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY PRIMARY CLINICS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 49. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 50. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 51. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 52. ARGENTINA CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 53. BRAZIL CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 54. CANADA CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 55. MEXICO CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 56. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 57. CALIFORNIA CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 58. FLORIDA CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 59. ILLINOIS CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 60. NEW YORK CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 61. OHIO CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 62. PENNSYLVANIA CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 63. TEXAS CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 64. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 65. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 66. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 67. CHINA CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 68. INDIA CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 69. INDONESIA CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 70. JAPAN CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 71. MALAYSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 72. PHILIPPINES CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 73. SOUTH KOREA CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 74. THAILAND CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 75. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 76. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 77. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 78. FRANCE CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 79. GERMANY CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 80. ITALY CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 81. NETHERLANDS CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 82. QATAR CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 83. RUSSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 84. SAUDI ARABIA CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 85. SOUTH AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 86. SPAIN CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 87. UNITED ARAB EMIRATES CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 88. UNITED KINGDOM CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 89. GLOBAL CLINICAL LABORATORY TESTS MARKET: FPNV POSITIONING MATRIX
  • FIGURE 90. GLOBAL CLINICAL LABORATORY TESTS MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 91. GLOBAL CLINICAL LABORATORY TESTS MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 92. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CLINICAL LABORATORY TESTS MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL CLINICAL LABORATORY TESTS MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 4. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL TESTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 5. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY BUN CREATININE TESTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 6. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPLETE BLOOD COUNT, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 7. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL TESTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 8. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY ELECTROLYTES TESTING, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 9. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY HBA1C TESTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 10. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY HGB/HCT TESTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 11. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY LIPID PANEL TESTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 12. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY LIVER PANEL TESTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 13. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 14. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY BILE DUCT OBSTRUCTION, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 15. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY BONE DISEASE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 16. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY HEPATITIS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 17. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY LIVER CANCER, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 18. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY LIVER CIRRHOSIS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 19. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY RENAL PANEL TESTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 20. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 21. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY CENTRAL LABORATORIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 22. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY PRIMARY CLINICS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 23. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 24. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 25. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 26. ARGENTINA CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 27. ARGENTINA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 28. BRAZIL CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 29. BRAZIL CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 30. CANADA CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 31. CANADA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 32. MEXICO CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 33. MEXICO CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 34. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 35. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 36. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 37. CALIFORNIA CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 38. CALIFORNIA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 39. FLORIDA CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 40. FLORIDA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 41. ILLINOIS CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 42. ILLINOIS CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 43. NEW YORK CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 44. NEW YORK CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 45. OHIO CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 46. OHIO CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 47. PENNSYLVANIA CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 48. PENNSYLVANIA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 49. TEXAS CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 50. TEXAS CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 51. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 52. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 53. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 54. CHINA CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 55. CHINA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 56. INDIA CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 57. INDIA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 58. INDONESIA CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 59. INDONESIA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 60. JAPAN CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 61. JAPAN CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 62. MALAYSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 63. MALAYSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 64. PHILIPPINES CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 65. PHILIPPINES CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 66. SOUTH KOREA CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 67. SOUTH KOREA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 68. THAILAND CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 69. THAILAND CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 72. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 73. FRANCE CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 74. FRANCE CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 75. GERMANY CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 76. GERMANY CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 77. ITALY CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 78. ITALY CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 79. NETHERLANDS CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 80. NETHERLANDS CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 81. QATAR CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 82. QATAR CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 83. RUSSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 84. RUSSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 85. SAUDI ARABIA CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 86. SAUDI ARABIA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 87. SOUTH AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 88. SOUTH AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 89. SPAIN CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 90. SPAIN CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 91. UNITED ARAB EMIRATES CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 92. UNITED ARAB EMIRATES CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 93. UNITED KINGDOM CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 94. UNITED KINGDOM CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 95. GLOBAL CLINICAL LABORATORY TESTS MARKET: SCORES
  • TABLE 96. GLOBAL CLINICAL LABORATORY TESTS MARKET: BUSINESS STRATEGY
  • TABLE 97. GLOBAL CLINICAL LABORATORY TESTS MARKET: PRODUCT SATISFACTION
  • TABLE 98. GLOBAL CLINICAL LABORATORY TESTS MARKET: RANKING
  • TABLE 99. GLOBAL CLINICAL LABORATORY TESTS MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 100. GLOBAL CLINICAL LABORATORY TESTS MARKET: SHARE, BY COMPANY, 2020
  • TABLE 101. GLOBAL CLINICAL LABORATORY TESTS MARKET: MERGER & ACQUISITION
  • TABLE 102. GLOBAL CLINICAL LABORATORY TESTS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 103. GLOBAL CLINICAL LABORATORY TESTS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 104. GLOBAL CLINICAL LABORATORY TESTS MARKET: INVESTMENT & FUNDING
  • TABLE 105. GLOBAL CLINICAL LABORATORY TESTS MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 106. GLOBAL CLINICAL LABORATORY TESTS MARKET: LICENSE & PRICING
  • TABLE 107. GLOBAL CLINICAL LABORATORY TESTS MARKET: CONTACT DETAILS